SUBSCRIBE
SUBSCRIBE

Tenax Therapeutics

NEWS
Business
BioSpace Movers & Shakers, Feb. 4
Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.
February 3, 2022
 · 
9 min read
 · 
Alex Keown
Business
New CEOs Named at Two Biopharma Companies
Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.
July 8, 2021
 · 
2 min read
 · 
Vanessa Doctor, RN
IN THE PRESS
Drug Development
Oxygen Biotherapeutics, Inc. Announces Progress in its Phase IIb Clinical Trial of Oxycyte for the Treatment of Traumatic Brain Injury
July 1, 2013
 · 
1 min read
Business
Oxygen Biotherapeutics, Inc. Reports Financial Results for Fiscal Year 2013
June 27, 2013
 · 
1 min read
Drug Development
Oxygen Biotherapeutics, Inc. Reports Successful Completion of FDA Requested Immunocompetency Studies on Oxycyte®
June 19, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Receives Favorable NASDAQ Listing Decision
May 17, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Receives Favorable NASDAQ Listing Decision
May 16, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th
May 10, 2013
 · 
1 min read
Business
Oxygen Biotherapeutics, Inc. Reports Financial Results for the Third Quarter FY2013
March 19, 2013
 · 
1 min read
Business
Oxygen Biotherapeutics, Inc. Announces Third Quarter FY2013 Financial Results Conference Call and Webcast
March 14, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Enters Into Definitive Agreements for Financing for Up to $2.1 Million in Gross Proceeds
February 22, 2013
 · 
1 min read
Business
Oxygen Biotherapeutics, Inc. Enters License and Supply Agreement for Dermacyte® Products With the Cosmetics Division of Valor SA
February 12, 2013
 · 
1 min read
Load More
JOBS